IOmx Therapeutics

About:

iOmx Therapeutics focuses on the development of cancer immunotherapy treatments.

Website: https://iomx.com

Top Investors: Sofinnova Partners, Wellington Partners, M Ventures, MPM Capital, MIG Capital

Description:

iOmx Therapeutics focuses on the development of first-in-class cancer therapeutics addressing novel immune checkpoint modulators on tumor cells. By systematically screening human tumor cells, the Company has already identified a number of novel targets and analyzed their mode of action. The Company was founded on the successful concept of cancer immune-checkpoint therapy, which works by breaking down the inherent resistance mechanisms of tumors against immune attack. Immune resistance of tumors is often mediated by cell surface molecules that stimulate immune-inhibitory receptors on T cells. Reactivating the host immune response by neutralizing these negative interactions is the idea behind cancer immune-checkpoint therapy.